Additional information
White Powder
357336-20-0
ACI-026100
78.4-81.3°C
C11H20N2O2
212.29
Ambient
2-8°C
Anticonvulsant
Pharmacopeial Reference Standards
(?S,4R)-?-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide
(aS,4R)-a-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide
Briviact





![sec-BUTYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)